Fumio Furukawa
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment 33
- Biochemistry top 5%
- Biochemistry top 2%
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 9
-
- Genomics, phytochemicals, and oxidative stress 22
- Glutathione Transferases and Polymorphisms 18
-
- Synthesis and Biological Evaluation 10
-
- Drug Transport and Resistance Mechanisms 10
- Pancreatic and Hepatic Oncology Research 7
-
- Helicobacter pylori-related gastroenterology studies 10
- Co-authors
- Akiyoshi NishikawaMichihito TakahashiYûzo HayashiMasao HiroseKazuhiro ToyodaTakayoshi ImazawaRyohei HasegawaTakeshi Kokubo
- Cited by
- Cancer ResearchBiochemistry
- Journals
- JNCI Journal of the National Cancer Institute (1 paper)Biochemical and Biophysical Research Communications (1 paper)The Journal of Urology (1 paper)
- Partner nations
- JapanSouth KoreaSri Lanka
In The Last Decade
Fumio Furukawa
157 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 128
- Cancer Research 652
- Biochemistry 181
- Biochemistry 180
- Health, Toxicology and Mutagenesis 307
- Pharmacology 190
Countries citing papers authored by Fumio Furukawa
This map shows the geographic impact of Fumio Furukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Furukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Furukawa more than expected).
Fields of papers citing papers by Fumio Furukawa
This network shows the impact of papers produced by Fumio Furukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Furukawa. The network helps show where Fumio Furukawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fumio Furukawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 38 | |
| 2 | 2010 | 39 | |
| 3 | 2003 | 47 | |
| 4 | 2003 | 29 | |
| 5 | 2002 | 25 | |
| 6 | 2002 | 11 | |
| 7 | 2001 | 52 | |
| 8 | 2000 | 8 | |
| 9 | 2000 | 17 | |
| 10 | 1999 | 6 | |
| 11 | 1998 | 7 | |
| 12 | 1998 | 15 | |
| 13 | 1996 | 1 | |
| 14 | 1996 | 12 | |
| 15 | [A 13-week subchronic toxicity study of bisphenol A in B6C3F1 mice]. | 1994 | 6 |
| 16 | 1994 | 19 | |
| 17 | 1990 | 30 | |
| 18 | 1988 | 8 | |
| 19 | 1987 | 7 | |
| 20 | 1987 | 15 |
About Fumio Furukawa
Fumio Furukawa is a scholar working on Cancer Research, Biochemistry and Pharmacology, having authored 163 papers that have together received 2.5k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (33 papers), Genomics, phytochemicals, and oxidative stress (22 papers), Glutathione Transferases and Polymorphisms (18 papers), Synthesis and Biological Evaluation (10 papers), Drug Transport and Resistance Mechanisms (10 papers), Helicobacter pylori-related gastroenterology studies (10 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Cancer Research (652 citations), Biochemistry (181 citations) and Biochemistry (180 citations). Fumio Furukawa has collaborated with scholars based in Japan, South Korea and Sri Lanka. Frequent co-authors include Akiyoshi Nishikawa, Michihito Takahashi, Yûzo Hayashi, Masao Hirose, Kazuhiro Toyoda, Takayoshi Imazawa, Ryohei Hasegawa, Takeshi Kokubo, Hidetaka Sato and Yuji Kurokawa. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Biochemical and Biophysical Research Communications and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.